Lv1
20 积分 2023-04-30 加入
Simultaneous Affinity Maturation and Liability Removal from Antibodies
21小时前
已完结
An engineered ultrahigh affinity bi‐paratopic uPAR targeting agent confers enhanced tumor targeting
2天前
已完结
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
9天前
已完结
TROP2-Targeted Therapeutics in Development to Treat Gastrointestinal Tumors
10天前
已完结
Trop2 immunoPET/CT in clinical practice: facts and challenges
10天前
已完结
Targeting TROP2 Across Solid Tumors: The Clinical Profile and Role of Datopotamab Deruxtecan
10天前
已完结
Development of Cyclic Peptide‐Based Radiotracers for uPAR
12天前
已完结
A Novel PET/CT Tracer for Human Urokinase-Type Plasminogen Activator Receptor
12天前
已完结
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target
12天前
已完结
A Novel CD147-Targeting Nanobody for Immuno-PET Imaging of Liver Cancer
12天前
已完结
皖公网安备34019202002308
